RIGEL PHARMACEUTICALS INC — Institutional Ownership
Which tracked institutions hold RIGL, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
25
Funds holding
$172421124
Total value held
Buying
18 added/new · 7 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $75885690 | 1939818 | +170911 | +9.66% |
| 2 | State Street Corp | $40684565 | 1039994 | -80244 | -7.16% |
| 3 | Goldman Sachs Group Inc | $8871634 | 226780 | -212321 | -48.35% |
| 4 | Morgan Stanley | $7278237 | 186049 | +87181 | +88.18% |
| 5 | Northern Trust Corp | $5726425 | 146381 | +11811 | +8.78% |
| 6 | Bank Of America Corp /De/ | $4831556 | 123506 | -20625 | -14.31% |
| 7 | Franklin Resources Inc | $4825999 | 123364 | +9486 | +8.33% |
| 8 | Ubs Group Ag | $4809960 | 122954 | +122954 | NEW BUY |
| 9 | Bank Of New York Mellon Corp | $4233132 | 108209 | +8285 | +8.29% |
| 10 | Janus Henderson Group Plc | $3674114 | 135877 | +135877 | NEW BUY |
| 11 | Wells Fargo & Company/Mn | $2131727 | 54492 | +7360 | +15.62% |
| 12 | Principal Financial Group Inc | $2032088 | 51945 | +3299 | +6.78% |
| 13 | Jpmorgan Chase & Co | $1626991 | 41675 | +591 | +1.44% |
| 14 | Raymond James Financial Inc | $1596879 | 40820 | +2687 | +7.05% |
| 15 | Citigroup Inc | $1273981 | 32566 | +25365 | +352.24% |
| 16 | Invesco Ltd. | $1133149 | 28966 | +28966 | NEW BUY |
| 17 | Barclays Plc | $545059 | 13933 | -1265 | -8.32% |
| 18 | Sei Investments Co | $492168 | 12581 | -17611 | -58.33% |
| 19 | Prudential Financial Inc | $337527 | 8628 | -55780 | -86.60% |
| 20 | Ameriprise Financial Inc | $226427 | 5638 | +5638 | NEW BUY |
| 21 | Royal Bank Of Canada | $183000 | 4695 | +569 | +13.79% |
| 22 | Federated Hermes, Inc. | $15765 | 403 | +403 | NEW BUY |
| 23 | Atlantic Union Bankshares Corp | $3912 | 100 | +100 | NEW BUY |
| 24 | Pnc Financial Services Group, Inc. | $1056 | 27 | -5 | -15.62% |
| 25 | Amalgamated Financial Corp. | $83 | 27816 | +27816 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.